IN RE QUEST DIAGNOSTICS ERISA LITIGATION

CourtDistrict Court, D. New Jersey
DecidedMay 4, 2021
Docket2:20-cv-07936
StatusUnknown

This text of IN RE QUEST DIAGNOSTICS ERISA LITIGATION (IN RE QUEST DIAGNOSTICS ERISA LITIGATION) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
IN RE QUEST DIAGNOSTICS ERISA LITIGATION, (D.N.J. 2021).

Opinion

NOT FOR PUBLICATION UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

Civil Action No. 20-07936-SDW-LDW

In re Quest Diagnostics Incorporated OPINION ERISA Litigation May 4, 2021

WIGENTON, District Judge. Before this Court is Defendants Quest Diagnostics Incorporated, the Quest Benefits Administration Committee, and the Quest Investment Committee’s (collectively, “Defendants”) Motion to Dismiss (D.E. 20; D.E. 21 (“Br.”)) Plaintiffs Lawanda Lasha House Johnson, Rebecca A. Rice, Shalamar Curtis, and Raquel Aziz’s (“Plaintiffs”) Consolidated Complaint (D.E. 10 (“Compl.”)) pursuant to Federal Rules of Civil Procedure (“Rule”) 12(b)(1) and 12(b)(6). Jurisdiction is proper pursuant to 28 U.S.C. § 1331. Venue is proper pursuant to 29 U.S.C. § 1132(e). This opinion is issued without oral argument pursuant to Rule 78. For the reasons stated herein, Defendants’ Motion is DENIED. I. BACKGROUND AND PROCEDURAL HISTORY Plaintiffs are “participants and beneficiaries” in Quest Diagnostics Incorporated’s Profit Sharing Plan, a qualified tax-deferred defined-contribution retirement plan (the “Plan”). (Compl. ¶¶ 1, 2.) As of December 31, 2018, the Plan had 40,488 participants and account balances/total assets of $3.9 billion. (Id. ¶ 5.) The Plan is a multiple-employer 401(k) plan, in which participants direct their contributions to various investment options (the “Investment Menu”).1 (Id. ¶¶ 4, 22, 55.) Plan participants were charged investment management fees and a $31 per-participant annual fee for recordkeeping services. (Id. ¶¶ 33-40, 50.) At the relevant time, roughly thirteen of the Investment Menu options were target date funds, which allow participants to anticipate a

retirement date and invest funds more conservatively as retirement approaches. (Id. ¶ 27.) Fidelity Management & Research Company (“Fidelity”) is the “second largest target date fund provider by total assets” in the investment industry, and the target date funds that it offered included the Freedom funds (the “Active suite”) and the Freedom Index funds (the “Index suite”).2 (Id. ¶ 28.) The Investment Menu included the Active suite, rather than the Index suite. (Id. ¶¶ 28-31.) On June 29, 2020, Plaintiffs filed a Complaint alleging (1) breach of fiduciary duties, pursuant to the Employee Retirement Income Security Act of 1974, as amended 29 U.S.C. Section 1001, et seq. (“ERISA”), (2) failure to monitor, and, in the alternative to the ERISA claims, (3) breach of trust for imprudent Plan management. (D.E. 1 ¶¶ 75-90.) On October 2, 2020, Plaintiffs filed a Consolidated Class Action Complaint (“Consolidated Complaint”), which largely repeated

the same allegations regarding overall Plan mismanagement. (See generally Compl.) Defendants moved to dismiss pursuant to Rules 12(b)(1) and 12(b)(6) on December 15, 2020. (Br.) On

1 Defendants have delegated the administration of the Plan to the Administrative Committee, which “exercises discretionary authority and control to administer, construe, and interpret the Plan and its assets.” (Compl. ¶ 15.) “The Investment Oversight Committee is established by the Administrative Committee to assist Quest with the selection of investment funds offered for selection by Plan participants and is a fiduciary under ERISA ….” (Id. ¶¶ 15, 16.) In addition, the Plan established a trust to hold Plan assets, which is managed by Fidelity Management Trust Company. (Id. ¶ 25.)

2 The Consolidated Complaint focuses on three specific funds’ performance issues to illustrate Defendants’ broader alleged breaches: the target-date Freedom funds (the “Active Suite”), the non-target date DFA US Small Cap Value Portfolio (“DFA Fund”), and the non-target date Invesco Global Real Estate Fund (“Invesco Fund”) (collectively, the “Funds”). (Compl. ¶¶ 25-49.) January 14, 2021, Plaintiffs opposed. (D.E. 29.) On February 4, 2021, Defendants replied. (D.E. 30.) Since then, the parties have filed various supplemental letters.3 (D.E. 31-32, 35-40.) II. LEGAL STANDARD A. Federal Rule of Civil Procedure 12(b)(1)

Pursuant to Rule 12(b)(1), a party may move to dismiss for lack of subject matter jurisdiction and this Court “must accept as true all material allegations set forth in the complaint, and must construe those facts in favor of the nonmoving party.” Ballentine v. U.S., 486 F.3d 806, 810 (3d Cir. 2007); Fed. R. Civ. P. 12(b)(1). “[S]tanding is a jurisdictional matter,” id. (citations omitted), and a motion to dismiss may present either a facial or factual attack to subject matter jurisdiction. A facial attack contests the complaint’s sufficiency “‘because of a defect on its face,’ whereas a factual attack ‘asserts that the factual underpinnings of the basis for jurisdiction fail to comport with the jurisdictional prerequisites.’” Halabi v. Fed. Nat’l Mortg. Ass’n, 2018 WL 706483, at *2 (D.N.J. Feb. 5, 2018) (citations omitted). In a factual attack, “the court may consider and weigh evidence outside the pleadings to determine if it has jurisdiction.” Gould Elecs. Inc. v.

United States, 220 F.3d 169, 178 (3d Cir. 2000), holding modified by Simon v. United States, 341 F.3d 193 (3d Cir. 2003). A. Federal Rule of Civil Procedure 12(b)(6) When ruling on a motion to dismiss under Rule 12(b)(6), this Court’s inquiry is guided by the standards of Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (2007) and Ashcroft v. Iqbal, 556 U.S. 662 (2009). An adequate complaint includes “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R. Civ. P. 8(a)(2). Rule 8 “requires more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do.

3 To the extent this Court has considered the cases provided in these letters or unauthorized sur-replies, it has not considered superfluous argument. Factual allegations must … raise a right to relief above the speculative level[.]” Twombly, 550 U.S. at 555 (citations omitted). Pursuant to Rule 12(b)(6), a court must “accept all factual allegations as true, construe the complaint in the light most favorable to the plaintiff, and determine whether, under any reasonable reading of the complaint, the plaintiff may be entitled to relief.”

Phillips v. Cty. of Allegheny, 515 F.3d 224, 231 (3d Cir. 2008) (external citation omitted). However, “the tenet that a court must accept as true all of the allegations contained in a complaint is inapplicable to legal conclusions. Threadbare recitals of the elements of a cause of action, supported by mere conclusory statements, do not suffice.” Iqbal, 556 U.S. at 678.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Renfro v. Unisys Corp.
671 F.3d 314 (Third Circuit, 2011)
Loomis v. Exelon Corp.
658 F.3d 667 (Seventh Circuit, 2011)
Krim M. Ballentine v. United States
486 F.3d 806 (Third Circuit, 2007)
Braden v. Wal-Mart Stores, Inc.
588 F.3d 585 (Eighth Circuit, 2009)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Hecker v. Deere & Co.
556 F.3d 575 (Seventh Circuit, 2009)
Graden v. Conexant Systems, Inc.
574 F. Supp. 2d 456 (D. New Jersey, 2008)
Fifth Third Bancorp v. Dudenhoeffer
134 S. Ct. 2459 (Supreme Court, 2014)
Simon v. United States
341 F.3d 193 (Third Circuit, 2003)
John Meiners v. Wells Fargo & Company
898 F.3d 820 (Eighth Circuit, 2018)
Jennifer Sweda v. University of Pennsylvania
923 F.3d 320 (Third Circuit, 2019)
Latasha Davis v. Washington Univ. in St. Louis
960 F.3d 478 (Eighth Circuit, 2020)
Thole v. U. S. Bank N. A.
590 U.S. 538 (Supreme Court, 2020)
Kruger v. Novant Health, Inc.
131 F. Supp. 3d 470 (M.D. North Carolina, 2015)
Terraza v. Safeway Inc.
241 F. Supp. 3d 1057 (N.D. California, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
IN RE QUEST DIAGNOSTICS ERISA LITIGATION, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-quest-diagnostics-erisa-litigation-njd-2021.